Critically, low CHAC1 expression confers resistance to ferroptosis in several cancers, including hepatocellular carcinoma, gastric cancer, prostate cancer, and oral squamous cell carcinoma. This evidence concerns the gene CHAC1 and oral cavity squamous cell carcinoma.